New Horizon Health (HKSE:06606) FFO


HKSE:06606 New Horizon Health Ltd HKSE:06606
35 GF Score
Price HK$14.14
View Full Analysis

What is New Horizon Health FFO?

FFO (Funds from operations) only applies to REITs.

HKSE:06606
35GF Score
New Horizon Health Ltd HKSE:06606
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

New Horizon Health Business Description

Address 400 Jiang’er Road, 13th Floor, T1 Building, Binjiang District, Zhejiang, Hangzhou, CHN, 310052
New Horizon Health Ltd is engaged in early cancer screening and in-home testing in China. The company has an early detection and cancer screening-focused pipeline of five products and product candidates with an emphasis on colorectal cancer screening. The company focuses on cancer prevention and cure through screening and early detection. It generates maximum revenue from ColoClear and Pupu Tube products.
35GF Score

Get the complete analysis for HKSE:06606

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$14.14
Price